What were Sanofi Consumer Healthcare India Ltd's latest quarterly results?
Sanofi Consumer Healthcare India Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +50.0%
- Revenue Growth YoY: +46.8%
- Operating Margin: 36.0%
Sanofi Consumer Healthcare India Ltd: Stock Analysis & Fundamentals
Updated this weekSanofi Consumer Healthcare India Ltd (Pharma - MNC bulk Drugs) — fundamental analysis, earnings data, and key metrics. PE: 40.0. ROE: 113.0%. This stock is not currently in the Nifty 500 momentum outperformers list.
What's Happening
📊Debt increased 40% YoY — leverage rising
👔Promoter buying — stake up 10.9% this quarter
🌐FII stake decreased 2.3% this quarter
🏛️DII reducing — stake down 6.6%
Key Numbers
Current Price
₹4,086
Dividend Yield
1.35%
Market Cap
9.4K Cr
Valuation
N/AOther Top Pharma - MNC bulk Drugs Stocks Beating Nifty 500
Frequently Asked Questions: Sanofi Consumer Healthcare India Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Sanofi Consumer Healthcare India Ltd's current PE ratio?
Sanofi Consumer Healthcare India Ltd's current PE ratio is 40.0x.
- Current PE: 40.0x
- Market Cap: 9.4K Cr
- Dividend Yield: 1.35%
What is Sanofi Consumer Healthcare India Ltd's price-to-book ratio?
Sanofi Consumer Healthcare India Ltd's price-to-book ratio is 24.5x.
- Price-to-Book (P/B): 24.5x
- Book Value per Share: ₹167
- Current Price: ₹4086
Is Sanofi Consumer Healthcare India Ltd a fundamentally strong company?
Sanofi Consumer Healthcare India Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 111.0%
Is Sanofi Consumer Healthcare India Ltd debt free?
Sanofi Consumer Healthcare India Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹28 Cr
What is Sanofi Consumer Healthcare India Ltd's return on equity (ROE) and ROCE?
Sanofi Consumer Healthcare India Ltd's return ratios over recent years
- Dec 2024: ROCE 111.0%
Is Sanofi Consumer Healthcare India Ltd's cash flow positive?
Sanofi Consumer Healthcare India Ltd's operating cash flow is positive (Dec 2024).
- Cash from Operations (CFO): ₹439 Cr
- Free Cash Flow (FCF): ₹441 Cr
- CFO/PAT Ratio: 243% (strong cash conversion)
What is Sanofi Consumer Healthcare India Ltd's dividend yield?
Sanofi Consumer Healthcare India Ltd's current dividend yield is 1.35%.
- Dividend Yield: 1.35%
- Current Price: ₹4086
Who holds Sanofi Consumer Healthcare India Ltd shares — promoters, FII, DII?
Sanofi Consumer Healthcare India Ltd's shareholding pattern (Dec 2025)
- Promoters: 71.3%
- FII (Foreign): 2.8%
- DII (Domestic): 17.3%
- Public: 8.6%
Is promoter holding increasing or decreasing in Sanofi Consumer Healthcare India Ltd?
Sanofi Consumer Healthcare India Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 71.3% (Dec 2025)
- Previous Quarter: 71.3% (Sep 2025)
- Change: 0.00% (stable)
Is Sanofi Consumer Healthcare India Ltd a new momentum entry or an established outperformer?
Sanofi Consumer Healthcare India Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Sanofi Consumer Healthcare India Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Sanofi Consumer Healthcare India Ltd may be worth studying
- Cash flow is positive — CFO ₹439 Cr
What is the investment thesis for Sanofi Consumer Healthcare India Ltd?
Sanofi Consumer Healthcare India Ltd investment thesis summary:
What is the future outlook for Sanofi Consumer Healthcare India Ltd?
Sanofi Consumer Healthcare India Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.